While cell-free systems are increasingly used for protein expression in structural and functional studies, several proteins are difficult to express or expressed only at low levels in cell-free lysates. Here, we report that fusion of the human immunoglobulin k light chain constant domain (Ck) at the C terminus of four representative proteins dramatically improved their production in the Escherichia coli S30 system, suggesting that enhancement of cell-free protein expression by Ck fusion will be widely applicable.
Production of proteins in heterologous systems is a major challenge in many areas of biological research and biopharmaceutical development. Cell-free protein synthesis is becoming a widely used alternative to cell-based methods for parallel production of proteins, providing a rapid route to the translation of genetic information into functional proteins (Spirin 2004) . Like in vitro methods, cellfree expression systems also allow proteins to be expressed and modified during translation under defined conditions that living cells may be incapable of reproducing. Several significant protein selection and display technologies, including ribosome display, mRNA display, and in situ protein arrays, also make use of cell-free protein expression systems (Hanes and Plückthun 1997; Taussig 1997, 2001) .
Several established systems are available, including rabbit reticulocyte, Escherichia coli S30, and wheat germ lysates, and more recently, mammalian cell extracts (Mikami et al. 2006 ) and the artificially assembled PURE system (Shimizu et al. 2001 ) have been introduced.
Efforts have been made to improve protein yield by identifying key factors affecting in vitro transcription and translation and developing modified protocols (Sawasaki et al. 2002; Spirin 2004; Calhoun and Swartz 2005) . They include the composition of the system itself, e.g., extracts of genetically engineered bacterial strains, various energy resources or amino acid concentrations, or use of defined components. Second, various production conditions have been used, such as dialysis, continuous flow, continuous exchange, hollow fiber, and bilayer systems (Sawasaki et al. 2002; Calhoun and Swartz 2005) . Despite these developments, some proteins are still only poorly expressed (or not at all) in cell-free systems. Codon optimization can be useful, but is time-consuming and often requires the assistance of prediction software.
Fusion of proteins to additional domains is widely used as a means of improving solubility and stability in heterologous in vivo expression systems (Shaki-Loewenstein et al. 2005) . Popular tags include maltose-binding protein (MBP), glutathione S-transferase (GST), thioredoxin (TRX), and NusA. Recently, fusion to a well-expressed N-terminal sequence of chloramphenicol acetyl transferase (CAT) has been reported to increase protein expression by up to 14-fold in an E. coli lysate (Son et al. 2006) . The constant domain of the immunoglobulin k light chain (Ck) has been used as a C-terminal fusion with single chain antibody fragments (scAb) and T-cell receptors (TCRs) to improve E. coli expression in vivo (Maynard et al. 2002 (Maynard et al. , 2005 and as a spacer for scAb during ribosome display in vitro (He and Taussig 1997) . However, it has not been applied so far to other proteins or for in vitro expression. Here, we report that fusion of the human Ck domain at the C terminus of several poorly expressed proteins significantly improves their expression in the E. coli S30 system. The use of Ck fusions thus provides a new approach to enhanced cell-free protein production. Moreover, the Ck domain can be used for immunodetection and affinity purification.
Materials and methods

Primers
The primers used in this study are as follows: Molecular biology reagents and cell-free system Nucleotides, agarose, the PCR Gel Extraction Kit, and the HRP-linked mouse anti-His antibody were from Sigma; Taq DNA polymerase from QIAGEN; HRP-linked antihuman k antibody from The Binding Site; NuPAGE BisTris gels from Invitrogen; PVDF Immobilon-P membranes from Millipore; Western Blot detection SuperSignal Kit from Pierce; and the coupled E. coli S30 cellfree expression system from Roche.
Construction of PCR fragments
The general PCR constructs used for cell-free protein synthesis are shown in Figure 1A . The 59-end contains a T7 promoter, a gene 10 enhancer, and an SD sequence (Roche kit) for efficient transcription and translation. The open reading frame (ORF) of the gene of interest was placed after the initiation codon ATG, followed by fusion in frame to the following in order: a flexible peptide linker, a double-(His) 6 tag, and two consecutive stop codons (TAATAA) (He and Taussig 2001) . When human Ck was included, it was placed between the gene ORF and the peptide linker. A transcription termination region was included at the 39-end of the constructs.
PCR generation of individual domains
The standard PCR mixture consisted of 5 mL of 103 PCR buffer, 10 mL of 53 Q, 4 mL of dNTP mix containing 2.5 mM each, 1.5 mL of forward and backward primers (16 mM each), 1 U of Taq DNA polymerase, 1-10 ng of template DNA, and water to a final volume of 50 mL.
(1) RTST7 domain, comprising T7 promoter, gene 10 enhancer, and SD sequence, was created using primers RTST7/B and PET7/F from a plasmid template used as a control in the cell-free system (Roche). (2) Double-(His) 6 tag domain, comprising a flexible peptide linker, two hexahistidine sequences, separated by an 11-amino-acid spacer sequence, and two consecutive stop codons (TAATAA), was generated using primers Linker-tag/B and Tterm/F on the plasmid template pTA-His (He and Taussig 2001) . (3) Ck-d(His) 6 tag domain was produced using primers HuC4/B and Tterm/F on a plasmid template, which encodes the Ck domain with the double-(His) 6 tag fused at the C terminus. (4) Open reading frame (ORF) of genes to be expressed was amplified using their corresponding plasmids (RZPD German Genome Resource Center, Heidelberg) as templates and individually designed primers. For generation of constructs without Ck, primers PErzpd/B and Rzpd-L/F were used, while PErzpd/B and RzpdCk/F were used for constructs with Ck.
Assembly PCR
The ORF of the gene of interest and the appropriate domain fragments were assembled by mixing in equimolar ratios (total DNA 50-100 ng) after elution from agarose gel (1%); adding into a PCR solution containing 2.5 mL of 103 PCR buffer, 1 mL of dNTP mix containing 2.5 mM each, 1 U of Taq DNA polymerase, and water to a final volume of 25 mL; and thermal cycling for eight cycles (94°C for 30 sec, 54°C for 1 min, and 72°C for 1 min). For constructs without Ck, the fragments assembled were the RTST7 domain, gene ORF, and the double-(His) 6 tag domain, while for the constructs with Ck, they were the RTST7 domain, gene ORF, and the Ck-d(His) 6 tag domain.
Amplification of PCR constructs
Assembled constructs were amplified by transferring 2 mL to a second PCR mixture in a final volume of 50 mL (as above) for a further 30 cycles using primers RTST7/B and T-term/F. Thermal cycling for 30 cycles (94°C for 30 sec, 54°C for 1 min, and 72°C for 1 min; finally, 72°C for 8 min). The final PCR construct was analyzed by agarose (1%) gel electrophoresis to determine quality and concentration by comparison with a known DNA marker. The PCR products may be used for cell-free expression with or without further purification.
Cell-free protein synthesis
Proteins were expressed from PCR constructs using the coupled E. coli S30 system, incubated for 4 h at 30°C. A standard reaction comprised 12 mL of E. coli S30 lysate, 12 mL of amino acids, 10 mL of reaction mix, 5 mL of reconstitution buffer, 1 mL of methionine, and 100-500 ng of PCR DNA, made to 50 mL with water. For a small-scale expression, 5-10 mL of the total reaction mixture was used.
Detection of proteins by Western blotting
Proteins expressed in the E. coli S30 lysate were mixed with an equal volume of 23 SDS buffer (100 mM Tris at pH 8.0, 5% SDS, 0.2% bromophenol blue, 20% glycerol), heated to 90°C for 5 min, loaded onto a 10% NuPAGE Bis-Tris gel, and run at 200 V. The separated bands were transferred to a PVDF membrane by electroblotting for 2 h at 80 mA. The membrane was blocked in 1% bovine serum albumin (BSA) in phosphate-buffered saline (PBS) for 1 h, then incubated with either HRP-linked mouse anti-His antibody (diluted 1:4000 in PBS/BSA) or HRPlinked mouse anti-k antibody (1:500 in PBS/BSA) for 1 h. The membrane was developed using the SuperSignal kit (Pierce) as per the manufacturer's instructions.
Results and Discussion
As a first example, we compared expression of human scAb fragment constructs with and without the human Ck domain. The two-domain (V H , V L ) scFv construct is a standard format for cell-based recombinant antibody expression (Holliger and Hudson 2005) . Anti-carcinoembryonic antigen (CEA) and anti-progesterone scFv fragments, created previously by ribosome display (He and Taussig 1997) , were assembled as fusions to a doublehexahistidine tag sequence [double-(His) 6 ] (He and Taussig 2001) or additionally to the Ck domain [Ckdouble-(His) 6 ] by PCR ( Fig. 1A ; Materials and Methods). After expression in the E. coli S30 system, Western blotting and detection by monoclonal anti-His antibody showed that neither scFv-double-(His) 6 fragment was expressed detectably, whereas both scFv-Ck-double-(His) 6 fusions successfully led to high expression yields (Fig. 1B,C) . Comparison with protein standards estimated that at least 100 mg/mL protein was produced after inclusion of the Ck domain. Sequencing of the PCR constructs confirmed that the reading frames were in all cases correct and that the only sequence differences were the presence or absence of Ck. It was also shown that the scFv-Ck-double-(His) 6 fragments were retained in the soluble fraction after high-speed centrifugation (15,000 rpm for 20 min) and bound their respective specific antigens (data not shown).
To test whether C-terminal fusion to the Ck domain could also improve expression of other proteins known to be synthesized at very low levels, we selected Rab22b (a GTP binding protein) and FKBP2 (FK506 binding protein). As double-(His) 6 constructs, both were barely detectable using anti-His antibody after expression in the E. coli S30 system (Fig. 1D,F, tracks 1) . In contrast, the yields of Rab22b-Ck-double-(His) 6 and FKBP2-Ckdouble-(His) 6 were high, and they were strongly detected on Western blotting by anti-His (Fig. 1D,F , tracks 2) and anti-Ck monoclonal antibodies (Fig. 1E,G) . Where the non-Ck-tagged protein was detectable on a Western blot, the increased expression through inclusion of the Ck domain was estimated as at least 10-50-fold.
Alternative tags, such as the CAT sequence, have been successfully added to target genes to increase expression, but have in general been N-terminal fusions (ShakiLoewenstein et al. 2005; Son et al. 2006 ). Well-expressed N-terminal tags increase translation initiation and thus production of the overall protein. In contrast, our work involves the novel use of a tag at the C terminus. Reasons for the increased expression are speculative, and effects on transcription or mRNA structure and stability cannot be excluded. Others have reported that addition of Ck to antibody fragments increases protein expression and thermal stability in vivo (Hayhurst 2000; Maynard et al. 2002) , and cellular expression of certain recombinant TCRs in E. coli is also improved by Ck fusion (Maynard et al. 2005) . It is possible that Ck stabilizes nascent polypeptides during cell-free synthesis, improves folding, or protects the fused proteins from degradation. However, in this study, all the constructs contain identical N and C termini (Fig. 1A) , so that the increased expression of the Ck-tagged proteins is unlikely to be explained by reduced C-terminal proteolysis.
In conclusion, our results demonstrate that fusion to the human Ck domain leads to high level expression of otherwise scarcely or very weakly expressed proteins in a standard cell-free system. We have shown that this is not restricted to antibody fragments, but can also be applied to unrelated, non-Ig domain proteins. Moreover, the availability of detection and binding reagents (e.g., antibodies, protein L) means that the Ck domain can be used both in Western blotting and other immunoassays, as well as in affinity purification, making it potentially useful as a multipurpose fusion tag. It has also been shown that a tag can be removed from an expressed protein by in situ specific cleavage at an engineered protease site in an E. coli cell-free translation mixture (Son et al. 2006) , which could be applied to generate the non-fusion protein as required. Recently, cellfree synthesized proteins have been directly used for studies by mass spectrometry or NMR (Jungbauer and Cavagnero 2006; Keppetipola et al. 2006) . Thus, Ck-domain fusions could find wide applicability in protein expression for structural and functional studies.
